Health & Pharmaceut…

The latest health and pharmaceuticals industry and company news and analysis from FriedlNews
Page 3/8

Sanochemia Achieves Turnaround

The Austrian pharmaceutical company could turn net results and EBIT into the profit zone. Sales were up too.

December 19, 2011

Intercell Receives Approval for Vaccine in India

The Austrian pharmaceutical company achieved an important milestone in the roll-out of its Japanese Encephalitis vaccine in endemic countries.

November 10, 2011

Intercell Still Reports Losses

The Austrian pharmaceutical company could reduce its net losses from € 50.8m to € 20.62m. For the full year the net loss expectations ranges up to € 40m.

November 8, 2011

Full Order Books For VTA

The Austrian water technology company expects a substantial rise in sales for 2012. Recently an order from Indonesia has been recorded.

October 30, 2011

Intercell Continues Development of Vaccines

The Austrian pharmaceutical company announces first data from its Phase I clinical trial with vaccine candidate to prevent Clostridium difficile infections.

October 24, 2011

Intercell: EU Invests € 30m in Research Program

The Austrian pharmaceutical company will receive co-funding for a collaborative research project from the European Union.

September 29, 2011

Intercell Looking for Private Equity Shareholder

According to Bloomberg, the Austrian pharmaceutical company negotiates with potential investors in order to strengthen the equity base.

September 27, 2011

Sanochemia´s Purchase of Alvetra & Werfft Completed

The Austrian pharmaceutical group acquires the former subsidiary again for € 5.2m.

September 21, 2011

Intercell Successfully Completes Vaccine Study in India

The Austrian biotech company achieved an important step in the licensure process of a vaccine for children.

September 16, 2011

Upper Austrian PAA Laboratories Acquired by GE Healthcare

The Pasching-based cell culture company will combine with the global provider of medical technologies and services. The deal is expected to close in the third quarter.

August 18, 2011